作者：
Vincent,T.L. [1]
;
Williams,R.O. [2]
;
Maciewicz,R. [3]
;
Silman,A. [4]
;
Garside,P. [5]
;
Bevan,S. [6]
;
Chanalaris,A. [7]
;
Chapman,V. [8]
;
Cope,A. [9]
;
Cruwys,S. [10]
;
Dell'Accio,F. [11]
;
Gaskin,P. [12]
;
Gilroy,D. [13]
;
Glasson,S. [14]
;
Hegen,M. [15]
;
McDougall,J. [16]
;
Moore,A. [17]
;
duSert,N.P. [18]
;
Perretti,M. [19]
;
Pitsillides,A. ;
Robinson,V. ;
Seed,M. ;
Thompson,S. ;
Walsh,D.A. ;
Williams,N.
作者单位：
Royal Veterinary College, London, United Kingdom
[1]
University College London, United Kingdom
[2]
NC3Rs, United Kingdom
[3]
Previously of Wyeth, United Kingdom
[4]
Pfizer, United Kingdom
[5]
UCB Pharma, United Kingdom
[6]
Oxford University, United Kingdom
[7]
Immunology and Inflammation, Institute of Infection, University of Glasgow, Glasgow, United Kingdom
[8]
Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom
[9]
GlaxoSmithKline, United Kingdom
[10]
Medical Director Arthritis Research UK, Chesterfield, United Kingdom
[11]
Astra Zeneca, United Kingdom
[12]
Respiratory and Inflammation Research Area, AstraZeneca, Loughborough, United Kingdom
[13]
University of Calgary, United Kingdom
[14]
Kings College London, United Kingdom
[15]
Nottingham University, United Kingdom
[16]
University of Bristol, United Kingdom
[17]
University of Nottingham, United Kingdom
[18]
Queen Mary University of London, United Kingdom
[19]
发布时间
2013-11-20
换一批
